Cubicin is a lipopeptide antibacterial indicated for complicated skin and skin structure infections and Staphylococcus aureus bloodstream infections (bacteremia). Merck is recalling 1 lot of Cubicin ® ...

Please provide your email address to receive an email when new articles are posted on . Researchers from the University of Padova in Italy found that an antibiotic combination regimen of Merrem and ...

Please provide your email address to receive an email when new articles are posted on . Cubist Pharmaceuticals Inc.is voluntarily recalling one lot of Cubicin (daptomycin for injection) to the user ...

Cubist Pharmaceuticals Settles CUBICIN Patent Litigation with Teva Cubist grants Teva a license to sell generic daptomycin in US either as of June 24, 2018—if CUBICIN is granted pediatric exclusivity ...

cubicin packaging Merck announced the launch of Cubicin RF (daptomycin for injection), a new formulation of Cubicin. Merck announced the launch of Cubicin RF (daptomycin for injection), a new ...

CUBICIN is not indicated for the treatment of pneumonia. Most adverse events reported in the complicated skin and skin structure infection clinical trials were mild or moderate in intensity and the ...

* Cubicin clinically proven to target both Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) with equal efficacy[1] * These serious infections can cause death in up to ...

Reported earnings came in at 58 cents, compared to a loss of 34 cents in the year-ago quarter. The earnings results comfortably surpassed the Zacks Consensus Estimate of 48 cents. Results in the ...

Swiss healthcare giant Novartis says that the European Commission has decided to expand use of the firm's antibiotic to treat two additional types of life-threatening hospital infections. Swiss ...

Dec 8 (Reuters) - Hospira Inc can launch a generic version of Cubist Pharmaceuticals Inc 's leading drug Cubicin as soon as 2016, a federal judge has ruled. U.S. District Judge Gregory Sleet in ...

(RTTNews) - Merck & Co., Inc., known as MSD outside the U.S. and Canada, has recalled one lot of intravenous antibiotic Cubicin (daptomycin for injection) 500 mg for the potential presence of ...

The FDA has approved broader use for Cubist Pharmaceuticals’ Cubicin intravenous antibiotic to also treat bloodstream infections, including a form of endocarditis.Cubist plans to market Cubicin for ...